{
 "PrintNo":"A10185","Session":2023,"Chamber":"ASSEMBLY","BillType":"Assembly","Published":"2024-05-10T10:49:20.617361Z",
 "Status":"IN_ASSEMBLY_COMM","Committee":"Insurance",
 "Milestones":[{"Type":"IN_ASSEMBLY_COMM","Date":"2024-05-10","Committee":"Insurance"}],
 "Actions":[{"Text":"REFERRED TO INSURANCE","Date":"2024-05-10","Chamber":"ASSEMBLY"}],
 "Sponsors":[{"ID":1474,"Name":"Phara Souffrant Forrest","Short":"FORREST"}],
 "Title":"Requires insurers to cover the substitution of a brand name prescription drug when the federal food and drug administration has declared that there is a supply issue with a generic drug",
 "Summary":"Requires insurers to cover the substitution of a brand name prescription drug when the federal food and drug administration has declared that there is a supply issue with a generic drug.",
 "LawSection":"Insurance Law","LawCode":"Amd §§3242 & 4329, Ins L",
 "ActClause":"AN ACT to amend the insurance law, in relation to substituting brand name prescription drugs in the case of a drug shortage"
}